Study of TG-1801 in Subjects With B-Cell Lymphoma

NCT03804996 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

TG Therapeutics, Inc.